

Can't find Follistim AQ? Learn about the best alternative fertility medications including Gonal-F, Menopur, and other options your doctor may recommend.
There's nothing more stressful than being in the middle of a fertility treatment cycle and learning that your pharmacy can't fill your Follistim AQ prescription. Whether it's a supply issue, an insurance problem, or a cost concern, the good news is that there are real alternatives that your doctor can prescribe.
Here's what you need to know about your options.
Follistim AQ (Follitropin Beta) is a recombinant form of follicle-stimulating hormone (FSH), manufactured by Organon. FSH is a hormone your body naturally produces to stimulate the growth and maturation of egg follicles in the ovaries.
In fertility treatment, Follistim is used to:
Follistim is injected subcutaneously (under the skin) using the Follistim Pen, typically for 7-12 days during a stimulation cycle. Doctors monitor your response with ultrasounds and blood tests to adjust the dose. For a deeper dive, read our post on how Follistim works.
Understanding the mechanism helps you see why alternatives can work — they target the same biological pathway.
There are several common reasons patients look for Follistim alternatives:
Gonal-F is the most direct alternative to Follistim. Made by EMD Serono, it contains Follitropin Alfa — another recombinant form of FSH. Both Follistim and Gonal-F work the same way and are considered functionally interchangeable in most fertility protocols.
Key facts about Gonal-F:
Clinical studies show comparable outcomes between Gonal-F and Follistim in terms of eggs retrieved, fertilization rates, and pregnancy rates. If your pharmacy has Gonal-F but not Follistim, switching is usually straightforward — your doctor just needs to adjust the prescription.
Menopur, made by Ferring Pharmaceuticals, is a purified urinary-derived gonadotropin that contains both FSH and LH (luteinizing hormone) activity. Unlike Follistim, which provides FSH only, Menopur adds LH to the mix.
Key facts about Menopur:
Menopur is not a one-to-one swap for Follistim since the LH component changes the hormone profile. However, many fertility doctors use Menopur-based protocols effectively, and it may be a good option if Follistim is unavailable.
Pergoveris is a combination recombinant product containing both FSH and LH. It's specifically designed for women with severe FSH and LH deficiency who need both hormones for adequate follicular development.
Key facts about Pergoveris:
Clomid is an oral fertility medication — no injections required. It works differently than Follistim by blocking estrogen receptors in the brain, which triggers the body to produce more FSH naturally.
Key facts about Clomid:
Clomid isn't a direct replacement for Follistim in IVF cycles, but if you're doing a less intensive treatment like timed intercourse or IUI, your doctor may consider it as a less expensive starting point.
This is a decision you should make with your reproductive endocrinologist. Some factors they'll consider:
For more information on finding Follistim or its alternatives at pharmacies near you, try Medfinder. And if you need help finding a fertility specialist, read our guide on how to find a doctor who can prescribe Follistim.
Not being able to fill your Follistim prescription doesn't mean your fertility journey is on hold. Gonal-F, Menopur, Pergoveris, and even Clomid can be effective alternatives depending on your specific situation. The most important step is talking to your doctor right away — the sooner they know about the issue, the sooner they can adjust your plan.
For the latest information on Follistim availability and shortage updates, check out our Follistim shortage update for 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.